Skip to content
lifestyle.brickvest.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Sanofi Winthrop Industrie
Press Release: Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid
May 19, 2026
Press release: Availability of the Q1 2026 aide-mémoire
May 19, 2026
Press Release: Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease
May 17, 2026
Press Release: Sanofi announces the signing of a share buyback mandate for up to €1 billion
February 3, 2026
←
Previous Page
1
2
3
4